Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.
2.
3.
4.

The prophylactic effect of 5-aminosalicylic acid and salazosulphapyridine on degraded-carrageenan-induced colitis in guinea pigs.

Jensen BH, Andersen JO, Poulsen SS, Skov Olsen P, Nørby Rasmussen S, Hansen SH, Hvidberg EF.

Scand J Gastroenterol. 1984 May;19(3):299-303.

PMID:
6146186
5.
6.
7.

5-ASA-glutamate protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid.

Clerici C, Gentili G, Pellicciari R, Gresele P, Mezzasoma AM, Giansanti M, Clementi M, Bartoli G, Balò S, Modesto R, Aburbeh AG, Morelli O, Morelli A.

Ital J Gastroenterol Hepatol. 1998 Aug;30(4):385-90.

PMID:
9789134
8.

Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.

Jung Y, Kim HH, Kim H, Kong H, Choi B, Yang Y, Kim Y.

Eur J Pharm Sci. 2006 May;28(1-2):26-33. Epub 2006 Feb 7.

PMID:
16455235
9.

The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.

Cohen HD, Das KM.

J Clin Gastroenterol. 2006 Aug;40 Suppl 3:S150-4. Review.

PMID:
16885699
10.

Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.

D'Arienzo A, Manguso F, Castiglione GN, Vicinanza G, Scaglione G, Bennato R, Sanges M, Mazzacca G.

Ital J Gastroenterol Hepatol. 1998 Jun;30(3):254-7.

PMID:
9759590
11.

Distribution and anti-inflammatory effect of mesalazine on carrageenan-induced colitis in the rabbit.

Kitano A, Matsumoto T, Oshitani N, Nakagawa M, Yasuda K, Watanabe Y, Tomobuchi M, Obayashi M, Tabata A, Fukushima R, Okabe H, Nakamura S, Obata A, Okawa K, Kobayashi K.

Clin Exp Pharmacol Physiol. 1996 Apr;23(4):305-9.

PMID:
8717066
12.

Encapsulated mesalamine granules (Apriso) for ulcerative colitis.

[No authors listed]

Med Lett Drugs Ther. 2009 May 18;51(1312):38-9. Review.

PMID:
19448588
13.

Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.

Xiao ZL, Biancani P, Carey MC, Behar J.

Hepatology. 2003 Jun;37(6):1442-50.

PMID:
12774024
14.

A mesalazine enema for ulcerative colitis.

[No authors listed]

Drug Ther Bull. 1994 May 19;32(5):38-9. Review.

PMID:
7635028
15.

5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.

Ikeda I, Tomimoto A, Wada K, Fujisawa T, Fujita K, Yonemitsu K, Nozaki Y, Endo H, Takahashi H, Yoneda M, Inamori M, Kubota K, Saito S, Nagashima Y, Nakagama H, Nakajima A.

Clin Cancer Res. 2007 Nov 1;13(21):6527-31.

16.
17.

Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: results from a randomized controlled study.

Yokoyama H, Takagi S, Kuriyama S, Takahashi S, Takahashi H, Iwabuchi M, Takahashi S, Kinouchi Y, Hiwatashi N, Tsuji I, Shimosegawa T.

Inflamm Bowel Dis. 2007 Sep;13(9):1115-20.

PMID:
17455207
18.
19.

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis.

Frieri G, Giacomelli R, Pimpo M, Palumbo G, Passacantando A, Pantaleoni G, Caprilli R.

Gut. 2000 Sep;47(3):410-4.

20.

Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.

Tozaki H, Odoriba T, Okada N, Fujita T, Terabe A, Suzuki T, Okabe S, Muranishi S, Yamamoto A.

J Control Release. 2002 Jul 18;82(1):51-61.

PMID:
12106976

Supplemental Content

Support Center